Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy

Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy

Show other versions (1)

Intensive induction therapy-in acute myeloid leukemia (AML), as in some other systemic malignancies- is a strategy fundamentally different from post-remission strategies. Approaches like consolidation treatment, prolonged mainte&not;nance, and autologous or allogeneic transplantation in the...

Full description

Bibliographic Details
Main Authors:	Thomas Büchner, Wolfgang Hiddemann, Wolfgang E. Berdel, Bernhard Wörmann, Helmut Löffler, Claudia Schoch, Torsten Haferlach, Wolf-Dieter Ludwig, Georg Maschmeyer, Eva Lengelder, Peter Staib, Reinhard Andreesen, Leopold Balleisen, Detlef Haase, Hartmut Eimermacher, Andrea Schumacher, Carlo Aul, Herbert Rasche, Jens Uhlig, Andreas Grüneisen, Hans Edgar Reis, Joachim Hartlapp, Wolf-Dietrich Hirschmann, Hans-Josef Weh, Hermann-Josef Pielken, Winfried Gassmann, Maria-Cristina Sauerland, Achim Heinecke for the German AML Cooperative Group
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2004-07-01
Series:	International Journal of Hematology-Oncology and Stem Cell Research
Subjects:	double induction high-dose AraC daunorubicin dosage
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4468.pdf&manuscript_id=4468

Similar Items

Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy
by: Thomas Büchner, et al.
Published: (2004-03-01)

Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo-therapy
by: Thomas Büchner, et al.
Published: (2004-03-01)

Acute Myeloid Leukemia (AML): The Role of Maintenance Chemo¬therapy
by: Thomas Büchner, et al.
Published: (2004-07-01)

Potential effects of pomegranate on lipid peroxidation and pro-inflammatory changes in daunorubicin-induced cardiotoxicity in rats
by: Hayder M Al-Kuraishy, et al.
Published: (2016-01-01)

Carvedilol Attenuates Inflammatory-Mediated Cardiotoxicity in Daunorubicin-Induced Rats
by: Punniyakoti T. Veeravedu, et al.
Published: (2011-03-01)

Rational Design of Daunorubicin C-14 Hydroxylase Based on the Understanding of Its Substrate-Binding Mechanism
by: Jing Zhang, et al.
Published: (2023-05-01)

Electrocardiographic characteristics of Nigerian children on anthracycline-based chemotherapy: A preliminary report
by: I D Peter, et al.
Published: (2017-01-01)

Oxaliplatin combined with daunorubicin induces apoptosis of colon cancer cell line HT-29
by: TIAN Chun-yang, LIU Xiao-zheng, FAN Jun-chao
Published: (2020-03-01)

Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial
by: Guillaume Drevin, et al.
Published: (2022-04-01)

Cardiolipin for Enhanced Cellular Uptake and Cytotoxicity of Thermosensitive Liposome-Encapsulated Daunorubicin toward Breast Cancer Cell Lines
by: Hamad Alrbyawi, et al.
Published: (2022-10-01)

Self-Assembled Daunorubicin/Epigallocatechin Gallate Nanocomplex for Synergistic Reversal of Chemoresistance in Leukemia
by: Ki Hyun Bae, et al.
Published: (2022-12-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Quercetin as a Potential Modulator of P-Glycoprotein Expression and Function in Cells of Human Pancreatic Carcinoma Line Resistant to Daunorubicin
by: Piotr Dziegiel, et al.
Published: (2010-02-01)

N-Alkylation of Anthracycline Antibiotics by Natural Sesquiterpene Lactones as a Way to Obtain Antitumor Agents with Reduced Side Effects
by: Margarita Neganova, et al.
Published: (2021-05-01)

Effects of Royal Jelly on Apoptosis and the Expression of Apoptotic Genes on Testicular Tissue in Male Balb/C Mice Treated with Daunorubicin
by: Mansour Safaei Pourzamani, et al.
Published: (2023-05-01)

pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines
by: Hamad Alrbyawi, et al.
Published: (2022-05-01)

Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin
by: Kumar Atul, et al.
Published: (1994-01-01)

Protective Effects of Royal Jelly on the Reproductive System of Male Mice Treated with Daunorubicin
by: Mansour Safaei Pourzamani, et al.
Published: (2022-03-01)

A Pilot Study of Matrix Metalloproteinases on the Model of Daunorubicin-induced Cardiomyopathy in Rabbits
by: Anna Potáčová, et al.
Published: (2007-01-01)

Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment
by: Hussain Mubarak Al-Aamri, et al.
Published: (2021-04-01)

Alternating electric fields can improve chemotherapy treatment efficacy in blood cancer cell U937 (non-adherent cells)
by: Elham Homami, et al.
Published: (2023-09-01)

Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation
by: Bao W, et al.
Published: (2019-04-01)

Iodinin (1,6-Dihydroxyphenazine 5,10-Dioxide) from Streptosporangium sp. Induces Apoptosis Selectively in Myeloid Leukemia Cell Lines and Patient Cells
by: Lars Herfindal, et al.
Published: (2013-01-01)

Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma: the DD Protocol
by: Frederico Luiz Dulley, et al.

Assessment of oxidative stress in acute myeloid leukemia
by: Esfahani A, et al.
Published: (2011-02-01)

Fluorescence spectra of cardiac myosin and in vivo experiment: studies on daunorubicin-induced cardiotoxicity
by: Yang Liu, et al.
Published: (2015-12-01)

Design and performance investigation of electrospun PVA nanofibers containing core-shell nanostructures for anticancer drug delivery
by: Sakineh Kavyanifar, et al.
Published: (2018-01-01)

The first attempt on fabrication of a nano-biosensing platform and exploiting first-order advantage from impedimetric data: Application to simultaneous biosensing of doxorubicin, daunorubicin and idarubicin
by: Shokoufeh Soleimani, et al.
Published: (2020-08-01)

Troponin-I and left ventricular function in pediatric high-risk acute lymphoblastic leukemia after daunorubicin treatment
by: Rinche Annur, et al.
Published: (2021-03-01)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment
by: Lalit S Raut
Published: (2015-01-01)

Chemotherapy Drugs Act Differently in the Expression and Somatic Mobilization of the <i>mariner</i> Transposable Element in <i>Drosophila simulans</i>
by: Taís Maus Bernardt, et al.
Published: (2022-12-01)

Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations
by: Piyush More, et al.
Published: (2023-08-01)

Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3
by: Tássia S. Tavares, et al.
Published: (2020-10-01)

Nanoengineered, magnetically guided drug delivery for tumors: A developmental study
by: Tieyu Chen, et al.
Published: (2022-10-01)

Creation of anthracycline prodrug
by: A. N. Tevyashova
Published: (2014-12-01)

Reduced Dose Intensity of Daunorubicin During Remission Induction for Low-Risk Patients With Acute Lymphoblastic Leukemia: A Retrospective Cohort Study of the Chinese Children’s Cancer Group
by: Yong Zhuang, et al.
Published: (2022-06-01)

Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia
by: Fu-rong Liu, et al.
Published: (2017-01-01)

MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin
by: Emeline Bollaert, et al.
Published: (2021-05-01)

High Throughput Fluorescence-Based In Vitro Experimental Platform for the Identification of Effective Therapies to Overcome Tumour Microenvironment-Mediated Drug Resistance in AML
by: Yoana Arroyo-Berdugo, et al.
Published: (2023-03-01)

Daunorubicin induced Stevens‐Johnson syndrome: A case report
by: Preeti Shakya, et al.
Published: (2021-07-01)